12/20/2024 12:19 PM | Abrdn Life Sciences Investors (Issuer) Wilson Ashton (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/20/2024 12:20 PM | Abrdn Life Sciences Investors (Issuer) Silue Kolotioloma (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/16/2024 10:48 AM | Abrdn Life Sciences Investors (Filer)
| Form N-CEN Annual Report for Registered Investment Companies | |
12/09/2024 12:05 PM | Abrdn Life Sciences Investors (Filer)
| Form N-CSR Certified shareholder report of registered management investment companies | |
11/27/2024 9:59 AM | Abrdn Life Sciences Investors (Filer)
| Form NPORT-P Monthly Portfolio Investments Report on Form NPORT | |
08/28/2024 1:07 PM | Abrdn Life Sciences Investors (Filer)
| Form NPORT-P Monthly Portfolio Investments Report on Form NPORT | |
08/27/2024 1:46 PM | Abrdn Life Sciences Investors (Issuer) Maher Bill (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
08/15/2024 9:46 AM | ABRDN ASIA-PACIFIC INCOME FUND, INC. (Filer) ABRDN AUSTRALIA EQUITY FUND, INC. (Filer) ABRDN EMERGING MARKETS EQUITY INCOME FUND, INC. (Filer) abrdn Funds (Filer) abrdn Global Dynamic Dividend Fund (Filer) ABRDN GLOBAL INCOME FUND, INC. (Filer) abrdn Global Infrastructure Income Fund (Filer) abrdn Global Premier Properties Fund (Filer) abrdn Healthcare Investors (Filer) abrdn Healthcare Opportunities Fund (Filer) abrdn Income Credit Strategies Fund (Filer) ABRDN JAPAN EQUITY FUND, INC. (Filer) Abrdn Life Sciences Investors (Filer) abrdn National Municipal Income Fund (Filer) abrdn Total Dynamic Dividend Fund (Filer) abrdn World Healthcare Fund (Filer)
| Form 40-17G | |
07/18/2024 1:56 PM | Abrdn Life Sciences Investors (Issuer) DiMartino Rose (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2024 10:22 AM | Abrdn Life Sciences Investors (Issuer) Saba Capital Management, L.P. (Reporting) Weinstein Boaz (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:36 PM | Abrdn Life Sciences Investors (Issuer) Saba Capital Management, L.P. (Reporting) Weinstein Boaz (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 2:18 PM | Abrdn Life Sciences Investors (Issuer) Nichols Rebecca Suzanne (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
06/18/2024 2:28 PM | Abrdn Life Sciences Investors (Issuer) Taggart Michael (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
06/14/2024 12:59 PM | Abrdn Life Sciences Investors (Issuer) Saba Capital Management, L.P. (Reporting) Weinstein Boaz (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 1:34 PM | Abrdn Life Sciences Investors (Filer)
| Form N-CSRS | |
06/10/2024 7:45 AM | Abrdn Life Sciences Investors (Issuer) Saba Capital Management, L.P. (Reporting) Weinstein Boaz (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 4:09 PM | Abrdn Life Sciences Investors (Issuer) Saba Capital Management, L.P. (Reporting) Weinstein Boaz (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 4:11 PM | Abrdn Life Sciences Investors (Issuer) Saba Capital Management, L.P. (Reporting) Weinstein Boaz (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 8:15 AM | Abrdn Life Sciences Investors (Subject) Saba Capital Management, L.P. (Filed by)
| Form SC 13D/A | |
05/31/2024 2:08 PM | Abrdn Life Sciences Investors (Issuer) Saba Capital Management, L.P. (Reporting) Weinstein Boaz (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2024 8:13 AM | Abrdn Life Sciences Investors (Filer)
| Form DEFA14A | |
05/23/2024 6:41 PM | Abrdn Life Sciences Investors (Issuer) Saba Capital Management, L.P. (Reporting) Weinstein Boaz (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2024 11:34 AM | Abrdn Life Sciences Investors (Issuer) Saba Capital Management, L.P. (Reporting) Weinstein Boaz (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/14/2024 12:50 PM | Abrdn Life Sciences Investors (Issuer) Saba Capital Management, L.P. (Reporting) Weinstein Boaz (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2024 9:31 AM | Abrdn Life Sciences Investors (Issuer) Saba Capital Management, L.P. (Reporting) Weinstein Boaz (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 3:50 PM | Abrdn Life Sciences Investors (Issuer) Saba Capital Management, L.P. (Reporting) Weinstein Boaz (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2024 9:52 AM | Abrdn Life Sciences Investors (Subject) Saba Capital Management, L.P. (Filed by)
| Form SC 13D/A | |
04/26/2024 10:40 AM | Abrdn Life Sciences Investors (Issuer) Saba Capital Management, L.P. (Reporting) Weinstein Boaz (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/23/2024 7:00 PM | Abrdn Life Sciences Investors (Issuer) Saba Capital Management, L.P. (Reporting) Weinstein Boaz (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/22/2024 3:12 PM | Abrdn Life Sciences Investors (Filer)
| Form DEF 14A | |
04/22/2024 2:08 PM | Abrdn Life Sciences Investors (Issuer) Saba Capital Management, L.P. (Reporting) Weinstein Boaz (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 7:05 AM | Abrdn Life Sciences Investors (Issuer) Saba Capital Management, L.P. (Reporting) Weinstein Boaz (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/17/2024 7:32 AM | Abrdn Life Sciences Investors (Subject) Saba Capital Management, L.P. (Filed by)
| Form SC 13D/A | |
04/12/2024 8:20 AM | Abrdn Life Sciences Investors (Issuer) Goetz Kathleen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 11:38 AM | Abrdn Life Sciences Investors (Issuer) Tse Loretta (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
02/29/2024 11:37 AM | Abrdn Life Sciences Investors (Filer)
| Form NPORT-P Monthly Portfolio Investments Report on Form NPORT | |
02/07/2024 6:55 AM | Abrdn Life Sciences Investors (Subject) Saba Capital Management, L.P. (Filed by)
| Form SC 13D/A | |
01/12/2024 10:41 AM | Abrdn Life Sciences Investors (Subject) Saba Capital Management, L.P. (Filed by)
| Form SC 13D/A | |
01/04/2024 1:23 PM | Abrdn Life Sciences Investors (Issuer) Reit Todd (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 3:34 PM | Abrdn Life Sciences Investors (Issuer) Maher Bill (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2023 6:54 AM | Abrdn Life Sciences Investors (Subject) Saba Capital Management, L.P. (Filed by)
| Form SC 13D | |
Has Trump Finally Gone Too Far? (Ad) Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks.
It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives.
But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars.
And here's the good news. Register For The Webinar To Discover |
12/22/2023 1:12 PM | Abrdn Life Sciences Investors (Issuer) Ritchie Ben (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/22/2023 1:15 PM | Abrdn Life Sciences Investors (Issuer) Duitz Joshua (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |